Sunrise Pharmaceutical Inc.
37 drugs in NADAC|37 Generic,0 Brand
Sunrise Pharmaceutical Inc. lists 37 NDCs in the CMS NADAC file (37 generic, 0 brand), at an average NADAC of $0.18 per unit, with a week-over-week move of +0.8% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
37
37G / 0B
Avg Price / Unit
$0.1806
$0.02 – $0.53
Avg 7d Change
+0.84%
Across 34 drugs with changes
7d Activity
of 37 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
phentermine hydrochloride market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Central Nervous System Stimulant therapeutic class
Review the broader class where Sunrise Pharmaceutical Inc. has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Sunrise Pharmaceutical Inc. make?
Sunrise Pharmaceutical Inc. lists 37 NDCs in the CMS NADAC file — 37 generic and 0 brand products.
What is the average price of Sunrise Pharmaceutical Inc. drugs?
The average NADAC across Sunrise Pharmaceutical Inc.'s portfolio is $0.1806 per unit, ranging from $0.0201 to $0.5292.
What types of drugs does Sunrise Pharmaceutical Inc. make?
Sunrise Pharmaceutical Inc. makes drugs across 9 FDA pharmacologic classes. The most common by NDC count are Central Nervous System Stimulant (32), Sympathomimetic Amine Anorectic (10), Anticholinergic (7), Antihistamine (6), Barbiturate (2).
Has Sunrise Pharmaceutical Inc. had any drug recalls?
No FDA enforcement recalls are matched to Sunrise Pharmaceutical Inc. in the openFDA feed.
How has Sunrise Pharmaceutical Inc.'s pricing changed recently?
Over the past 7 days, 17 Sunrise Pharmaceutical Inc. products rose and 17 fell, with a portfolio-wide average change of +0.8%.